Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 2,506 shares at $18.76 ($48K) on 2025-01-06, disclosed to the SEC on 2025-01-06.
Scheduled sale ($48k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.10 | 2,066 | $39K | 82.7% |
| 2 | $18.76 | 440 | $8K | 17.3% |
| Total | $19.04 avg | 2,506 | $48K | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $346K | — | Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |